
Abemaciclib is a targeted cancer therapy (CDK4/6 inhibitor) used to treat HR-positive, HER2-negative advanced or metastatic breast cancer, often in combination with hormone therapy, by slowing cancer cell growth.
| Manufacturer | Eli Lilly and Company |
| Generic Name | Abemaciclib |
| Strength | 150mg |
| Pack size | 14 Tablets |
| Used For | Metastatic breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 Tablets | $370 | £274 | A$515 | ₱23,195 | د.ت1,077.07 | ₩495,467 | lei 1,675 | HK$2,902 | RM1,505 | ฿12,217 | S$469 | د.إ1,359.01 | ر.س1,389.35 | ر.ق1,347.17 | د.ك112.850 |
Abemaciclib is a CDK4/6 inhibitor. It blocks cyclin-dependent kinases (CDK4 and CDK6), which are proteins that help cancer cells divide. By stopping these signals, it prevents cancer cells from multiplying.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.